TELADOC HEALTH INC
TDOCNYSE🏆 #1920 by market capUS Equity
$543.28▲ $37.65 (+6.93%)
Simulated price1h—
24h▲ 6.9%
7d▲ 7739.5%
14d▲ 5805.2%
30d▲ 5529.8%
1y▲ 7808.0%
🏦Market Cap
$1.24B
Small Cap
📈Revenue Growth (YoY)
-2.1%
Declining
📊Gross Margin
69.0%
High
💵FCF Margin
5.8%
Moderate
⚖️P/S Ratio
0.5x
Cheap
Otter Score
63
Fair
Trading Snapshot
- Day Range
- $538.48 – $547.64
- 52-Week Range
- $4.40 – $9.89
- Volume
- $2.00B
- Avg Volume
- $2.54B
- Shares Outstanding
- 181.7M
- Next Earnings
- Sep 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.40B
- Last Q Revenue
- $635M
- P/E Ratio
- —
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-0.99
- Dividend Yield
- —
Why Investors Own TDOC
- ✓High-growth profile — revenue up -0.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 60% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$2.40B▼ −0.1% YoY
Gross Margin (TTM)
60.4%▲ +2.7% YoY
Operating Income (TTM)
$718M▼ −0.1% YoY
Free Cash Flow (TTM)
$332M▼ −0.1% YoY
About TELADOC HEALTH INC
A company profile for TELADOC HEALTH INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
63/100
Analyst Price Target
ⓘAverage Target
$660.45
▲ +21.6% Upside
High Target$719.79
Low Target$592.06
Based on 13 analysts
Latest News & Updates
🚀
CNBC·2h ago
TELADOC HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift TDOC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
TELADOC HEALTH INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.